Effects of Lutein Supplementation on Subclinical Atherosclerosis
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 192 participants.
Also called NCT01534533
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 192 participants
- Sponsor
- Registry
-
NCT01534533
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01534533. Randomized; quadruple masking; primary purpose prevention. Start 2010-06 (registry gives no type); primary completion 2011-06 (actual). Results posted on 2012-10-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Lutein Supplementation on Subclinical Atherosclerosis
- Condition
- Carotid Atherosclerosis
- Condition
- Carotid Intimal Medial Thickness 1
- Intervention (Dietary supplement)
- Placebo
- Intervention (Dietary supplement)
- Lutein group
- Intervention (Dietary supplement)
- Combination group
- Intervention (Dietary supplement)
- Normal lutein control group
- Lead sponsor
- Peking University
Record details
- Record id
cardio:ct-nct01534533- Content hash
00aa42f76fa2b4be01d9c0804504357c0d1344104c585ad70a4f9ed83be6b033